IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression.

Détails

Ressource 1Télécharger: 38943641.pdf (5657.79 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_9ACECC97A082
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression.
Périodique
Cell reports
Auteur⸱e⸱s
Hirsch T., Neyens D., Duhamel C., Bayard A., Vanhaver C., Luyckx M., Sala de Oyanguren F., Wildmann C., Dauguet N., Squifflet J.L., Montiel V., Deschamps M., van der Bruggen P.
ISSN
2211-1247 (Electronic)
Statut éditorial
Publié
Date de publication
23/07/2024
Peer-reviewed
Oui
Volume
43
Numéro
7
Pages
114401
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Human CD8 tumor-infiltrating lymphocytes (TILs) with impaired effector functions and PD-1 expression are categorized as exhausted. However, the exhaustion-like features reported in TILs might stem from their activation rather than the consequence of T cell exhaustion itself. Using CRISPR-Cas9 and lentiviral overexpression in CD8 T cells from non-cancerous donors, we show that the T cell receptor (TCR)-induced transcription factor interferon regulatory factor 4 (IRF4) promotes cell proliferation and PD-1 expression and hampers effector functions and expression of nuclear factor κB (NF-κB)-regulated genes. While CD8 TILs with impaired interferon γ (IFNγ) production exhibit activation markers IRF4 and CD137 and exhaustion markers thymocyte selection associated high mobility group box (TOX) and PD-1, activated T cells in patients with COVID-19 do not demonstrate elevated levels of TOX and PD-1. These results confirm that IRF4 <sup>+</sup> TILs are exhausted rather than solely activated. Our study indicates, however, that PD-1 expression, low IFNγ production, and active cycling in TILs are all influenced by IRF4 upregulation after T cell activation.
Mots-clé
Humans, Programmed Cell Death 1 Receptor/metabolism, Programmed Cell Death 1 Receptor/genetics, CD8-Positive T-Lymphocytes/immunology, CD8-Positive T-Lymphocytes/metabolism, Cell Proliferation, Interferon Regulatory Factors/metabolism, Interferon Regulatory Factors/genetics, Interferon-gamma/metabolism, Lymphocyte Activation/immunology, COVID-19/immunology, COVID-19/virology, Lymphocytes, Tumor-Infiltrating/immunology, Lymphocytes, Tumor-Infiltrating/metabolism, SARS-CoV-2/immunology, NF-kappa B/metabolism, High Mobility Group Proteins, CD8 T cell, CP: Immunology, IRF4, NFAT, PD-1, TILs, TOX, dysfunction, exhaustion, proliferation, tumor
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/07/2024 14:22
Dernière modification de la notice
13/08/2024 6:57
Données d'usage